Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.
about
A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignmentA novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44Cleavage of a hydrophilic C-terminal domain increases growth-inhibitory activity of oncostatin MOncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cellsMolecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin MCytotoxicity of TNFalpha is regulated by integrin-mediated matrix signalingSerum-free cryopreservation of five mammalian cell lines in either a pelleted or suspended stateRapid cryopreservation of five mammalian and one mosquito cell line at -80 degrees C while attached to flasks in a serum free cryopreservative.TNF biology, pathogenic mechanisms and emerging therapeutic strategiesNecroptotic Cell Death Signaling and Execution Pathway: Lessons from Knockout MiceHistorical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journeyThe seventh zinc finger motif of A20 is required for the suppression of TNF-α-induced apoptosisA novel pathway for tumor necrosis factor-alpha and ceramide signaling involving sequential activation of tyrosine kinase, p21(ras), and phosphatidylinositol 3-kinaseIdentification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinaseAberrant expression of serpin squamous cell carcinoma antigen 2 in human tumor tissues and cell lines: evidence of protection from tumor necrosis factor-mediated apoptosisEffects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermiaEstablishment of a consistent L929 bioassay system for TNF-alpha quantitation to evaluate the effect of lipopolysaccharide, phytomitogens and cytodifferentiation agents on cytotoxicity of TNF-alpha secreted by adherent human mononuclear cellsAttenuation of soft-tissue sarcomas resistance to the cytotoxic action of TNF-α by restoring p53 functionIdentification and functional characterization of a novel binding site on TNF-alpha promoter.Evaluation of serum levels of tumour necrosis factor-alpha (TNF-alpha) and soluble IL-2 receptor (sIL-2R) and CD4, CD8 and natural killer (NK) populations during infrared pulsed laser device (IPLD) treatment.Molecular cloning, expression and characterization of ovine TNF alpha.HGF/SF activates glycolysis and oxidative phosphorylation in DA3 murine mammary cancer cells.Interferon gamma (IFNgamma ) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways.RNA processing is a limiting step for murine tumor necrosis factor beta expression in response to interleukin-2Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.The PtdIns 3-kinase/Akt pathway regulates macrophage-mediated ADCC against B cell lymphomaActivated CD4+ T cells enhance radiation effect through the cooperation of interferon-gamma and TNF-alpha.Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis.Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicinAmplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cellsGeneration of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2Myocardial apoptosis and mesenchymal stem cells with acute exercise.Statistical analysis of MPSS measurements: application to the study of LPS-activated macrophage gene expression.Tumour necrosis factor-alpha (TNF-alpha) in patients who have asbestosis and develop cancerPlatelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogensWnt/β-catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells.Loss of negative feedback control of nuclear factor-kappaB2 activity in lymphocytes leads to fatal lung inflammation.Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication.Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts.
P2860
Q22009378-6E71564C-9BB8-4CEB-878E-82A46EC5EAE3Q24297519-B6E2F4FD-56D5-4ED1-A23C-F3AC5DDA94F4Q24600562-AA6EADE1-2892-41BD-AD2E-CBF5CFB78CB1Q24627585-C8A4D7D4-4848-42D6-B43E-674EC004160CQ24633689-4EDFFEC6-6107-43B6-AE17-BE7D62277A7FQ24682392-0B0A185C-CD78-4E62-AA0D-4423DB6FB473Q24805349-95576665-368D-49AC-A0F8-CA387ADFEEE6Q24815917-C36F2EBC-D3BE-4197-95EF-72F52327CF79Q26776492-71E58FB6-BDF9-4B5B-8F19-CF5F4E5917E6Q26778547-4D63E908-370D-4400-84FC-9F90A37E5C45Q26991848-62F8B034-FB23-4244-BB25-10F6FD5ED277Q28117534-BF102DC1-ADB1-43E4-9C74-EE8A5BA3B5F2Q28142088-BBB1FBA0-44DB-4E5E-9434-926B055FB3A4Q28144774-B998C975-4F52-4678-9B1C-62283FA017A4Q28215215-43F8146E-118E-4CB3-9039-CE4A64AF592DQ28324480-4F41DBF4-EE1A-467C-BCCA-3F74E8AC3907Q28360538-109158C5-7F74-4F66-9738-2EBA8144011AQ28728301-9DAE3780-450F-4CBB-A7DC-81F042BB44EFQ30179445-F882C147-526F-4A05-B133-30BADEE7978AQ30737786-4537EA30-B397-4DCA-A27C-3EE942165E43Q30834362-BA417ABB-999E-49C9-B7DC-E418CA139CFEQ30929211-9A088FBC-FA59-463B-AB4D-EF52530DF917Q33181838-A58602DA-5122-40FA-8CE4-2206CCC22AC0Q33258491-1E488F5F-B58C-401C-AF87-182F2F968587Q33336314-2A12BDCB-C5D2-4962-946E-9C97E5A99BBDQ33400351-8716E4F9-F91E-4CA0-A180-41F34266B81DQ33533655-6DBEA721-DCC6-4CF0-AB00-82A6DF626E3CQ33562931-0A1F5941-FB77-46A3-87AF-8F10348DA1A5Q33585128-E0E8229E-117B-49D9-9DF5-194DC0C428A0Q33632011-0863C699-5944-4768-AB06-F869B7E86A16Q33648545-FF796222-7B68-4FB2-8026-B8F01EDC492EQ33800224-63016CE4-94AB-4D9A-A2B0-515C2B8C12DDQ33818294-B63ADC71-D6DF-4A9E-9EFA-BE004EEB4D73Q33819078-AED85CB2-6835-4A6F-B40C-9EB73E9AB8ABQ33836105-413202EA-8011-4005-9CA9-3025DC214414Q33873644-6AA85CA3-9081-4931-8981-537A95C1293DQ33882384-B687F01A-E871-4E28-AF41-BAD0C5322FEBQ33899892-30171505-3EF6-4440-A582-A2115CDB963DQ33923680-280BEDCD-B443-4E01-86AE-9D844BDA6C7CQ33989008-403647B0-AF10-4EB2-864E-060BBD9374FE
P2860
Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Recombinant human tumor necros ...... nd transformed cells in vitro.
@en
Recombinant human tumor necros ...... nd transformed cells in vitro.
@nl
type
label
Recombinant human tumor necros ...... nd transformed cells in vitro.
@en
Recombinant human tumor necros ...... nd transformed cells in vitro.
@nl
prefLabel
Recombinant human tumor necros ...... nd transformed cells in vitro.
@en
Recombinant human tumor necros ...... nd transformed cells in vitro.
@nl
P2093
P356
P1433
P1476
Recombinant human tumor necros ...... nd transformed cells in vitro.
@en
P2093
Aggarwal BB
Palladino MA Jr
Shepard HM
Sugarman BJ
P304
P356
10.1126/SCIENCE.3933111
P407
P577
1985-11-01T00:00:00Z